Development and preclinical evaluation of a vaccine targeting IL-4 and IL-13 for the treatment of allergic asthma

Allergy. 2021 Nov;76(11):3553-3555. doi: 10.1111/all.14998. Epub 2021 Jul 18.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asthma* / drug therapy
  • Humans
  • Interleukin-13
  • Interleukin-4
  • Vaccines*

Substances

  • Interleukin-13
  • Vaccines
  • Interleukin-4